Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Christopher Paul Crum, M.D.

Co-Author

This page shows the publications co-authored by Christopher Crum and Marisa Nucci.
Connection Strength

4.756
  1. Redefining early cervical neoplasia: recent progress. Adv Anat Pathol. 2007 Jan; 14(1):1-10.
    View in: PubMed
    Score: 0.346
  2. Biomarkers in diagnostic obstetric and gynecologic pathology: a review. Adv Anat Pathol. 2003 Mar; 10(2):55-68.
    View in: PubMed
    Score: 0.265
  3. Synovial Sarcoma of the Female Genital Tract: A Protean Mimic of Müllerian Neoplasia. Am J Surg Pathol. 2020 11; 44(11):1487-1495.
    View in: PubMed
    Score: 0.226
  4. Mural nodules in mucinous ovarian tumors represent a morphologic spectrum of clonal neoplasms: a morphologic, immunohistochemical, and molecular analysis of 13 cases. Mod Pathol. 2021 03; 34(3):613-626.
    View in: PubMed
    Score: 0.222
  5. Evidence for a Novel Endometrioid Carcinogenic Sequence in the Fallopian Tube With Unique Beta-Catenin Expression. Int J Gynecol Pathol. 2020 Mar; 39(2):163-169.
    View in: PubMed
    Score: 0.215
  6. HPV 6-associated HSIL/Squamous Carcinoma in the Anogenital Tract. Int J Gynecol Pathol. 2019 Sep; 38(5):493-497.
    View in: PubMed
    Score: 0.208
  7. Classic Vulvar Intraepithelial Neoplasia With Superimposed Lichen Simplex Chronicus: A Unique Variant Mimicking Differentiated Vulvar Intraepithelial Neoplasia. Int J Gynecol Pathol. 2019 Mar; 38(2):175-182.
    View in: PubMed
    Score: 0.201
  8. The fallopian tube, "precursor escape" and narrowing the knowledge gap to the origins of high-grade serous carcinoma. Gynecol Oncol. 2019 02; 152(2):426-433.
    View in: PubMed
    Score: 0.198
  9. Evidence for lineage continuity between early serous proliferations (ESPs) in the Fallopian tube and disseminated high-grade serous carcinomas. J Pathol. 2018 11; 246(3):344-351.
    View in: PubMed
    Score: 0.195
  10. Differentiated exophytic vulvar intraepithelial lesions are genetically distinct from keratinizing squamous cell carcinomas and contain mutations in PIK3CA. Mod Pathol. 2017 03; 30(3):448-458.
    View in: PubMed
    Score: 0.171
  11. Pseudobowenoid change of the vulva: a histologic variant of untreated condylata acuminatum. Mod Pathol. 1996 Apr; 9(4):375-9.
    View in: PubMed
    Score: 0.164
  12. Cervical squamocolumnar junction-specific markers define distinct, clinically relevant subsets of low-grade squamous intraepithelial lesions. Am J Surg Pathol. 2013 Sep; 37(9):1311-8.
    View in: PubMed
    Score: 0.137
  13. A novel blueprint for 'top down' differentiation defines the cervical squamocolumnar junction during development, reproductive life, and neoplasia. J Pathol. 2013 Feb; 229(3):460-8.
    View in: PubMed
    Score: 0.132
  14. Giant condyloma of the cervix: an uncommon entity associated with low-risk human papilloma virus infection. Am J Surg Pathol. 2013 Feb; 37(2):300-4.
    View in: PubMed
    Score: 0.132
  15. A discrete population of squamocolumnar junction cells implicated in the pathogenesis of cervical cancer. Proc Natl Acad Sci U S A. 2012 Jun 26; 109(26):10516-21.
    View in: PubMed
    Score: 0.126
  16. Fallopian tube correlates of ovarian serous borderline tumors. Am J Surg Pathol. 2011 Dec; 35(12):1759-65.
    View in: PubMed
    Score: 0.122
  17. Clinical outcome in diagnostically ambiguous foci of 'gland crowding' in the endometrium. Mod Pathol. 2010 Nov; 23(11):1486-91.
    View in: PubMed
    Score: 0.111
  18. Serous tubal intraepithelial carcinoma: diagnostic reproducibility and its implications. Int J Gynecol Pathol. 2010 Jul; 29(4):310-4.
    View in: PubMed
    Score: 0.110
  19. High-grade fimbrial-ovarian carcinomas are unified by altered p53, PTEN and PAX2 expression. Mod Pathol. 2010 Oct; 23(10):1316-24.
    View in: PubMed
    Score: 0.110
  20. Embryonic stem cell transcription factors and D2-40 (podoplanin) as diagnostic immunohistochemical markers in ovarian germ cell tumors. Int J Gynecol Pathol. 2009 Jul; 28(4):347-55.
    View in: PubMed
    Score: 0.103
  21. Coexisting intraepithelial serous carcinomas of the endometrium and fallopian tube: frequency and potential significance. Int J Gynecol Pathol. 2009 Jul; 28(4):308-15.
    View in: PubMed
    Score: 0.103
  22. Intercepting early pelvic serous carcinoma by routine pathological examination of the fimbria. Mod Pathol. 2009 Aug; 22(8):985-8.
    View in: PubMed
    Score: 0.102
  23. Adenofibroma of the fimbria: a common entity that is indistinguishable from ovarian adenofibroma. Int J Gynecol Pathol. 2008 Jul; 27(3):390-7.
    View in: PubMed
    Score: 0.096
  24. Serous carcinogenesis in the fallopian tube: a descriptive classification. Int J Gynecol Pathol. 2008 Jan; 27(1):1-9.
    View in: PubMed
    Score: 0.093
  25. A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J Pathol. 2007 Jan; 211(1):26-35.
    View in: PubMed
    Score: 0.086
  26. Hertig and beyond: a systematic and practical approach to the endometrial biopsy. Adv Anat Pathol. 2003 Nov; 10(6):301-18.
    View in: PubMed
    Score: 0.069
  27. Interobserver reproducibility of the diagnosis of differentiated exophytic vulvar intraepithelial lesion (DEVIL) and the distinction from its mimics. Histopathology. 2021 Dec; 79(6):957-965.
    View in: PubMed
    Score: 0.060
  28. Identification of a basal/reserve cell immunophenotype in benign and neoplastic endometrium: a study with the p53 homologue p63. Gynecol Oncol. 2001 Jan; 80(1):30-6.
    View in: PubMed
    Score: 0.057
  29. Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer. Cancer Res. 2021 01 01; 81(1):158-173.
    View in: PubMed
    Score: 0.056
  30. Uterine Tumor Resembling Ovarian Sex Cord Tumor (UTROSCT): A Morphologic and Molecular Study of 26 Cases Confirms Recurrent NCOA1-3 Rearrangement. Am J Surg Pathol. 2020 01; 44(1):30-42.
    View in: PubMed
    Score: 0.053
  31. Mucinous endometrial epithelial proliferations: a morphologic spectrum of changes with diverse clinical significance. Mod Pathol. 1999 Dec; 12(12):1137-42.
    View in: PubMed
    Score: 0.053
  32. Targeted Genomic Profiling of Female Adnexal Tumors of Probable Wolffian Origin (FATWO). Int J Gynecol Pathol. 2019 Nov; 38(6):543-551.
    View in: PubMed
    Score: 0.053
  33. Assessment of a Chemotherapy Response Score (CRS) System for Tubo-Ovarian High-Grade Serous Carcinoma (HGSC). Int J Gynecol Pathol. 2019 May; 38(3):230-240.
    View in: PubMed
    Score: 0.051
  34. Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids. Cancer Discov. 2018 11; 8(11):1404-1421.
    View in: PubMed
    Score: 0.049
  35. SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma. Mod Pathol. 2018 09; 31(9):1442-1456.
    View in: PubMed
    Score: 0.047
  36. Targeted Genomic Profiling Reveals Recurrent KRAS Mutations in Mesonephric-like Adenocarcinomas of the Female Genital Tract. Am J Surg Pathol. 2018 02; 42(2):227-233.
    View in: PubMed
    Score: 0.047
  37. Morphologic correlates of molecular alterations in extrauterine Müllerian carcinomas. Mod Pathol. 2016 08; 29(8):893-903.
    View in: PubMed
    Score: 0.041
  38. Differential expression of p-ERM, a marker of cell polarity, in benign and neoplastic oviductal epithelium. Int J Gynecol Pathol. 2013 Jul; 32(4):345-52.
    View in: PubMed
    Score: 0.034
  39. Stathmin-1 expression as a complement to p16 helps identify high-grade cervical intraepithelial neoplasia with increased specificity. Am J Surg Pathol. 2013 Jan; 37(1):89-97.
    View in: PubMed
    Score: 0.033
  40. Peritoneal dissemination complicating morcellation of uterine mesenchymal neoplasms. PLoS One. 2012; 7(11):e50058.
    View in: PubMed
    Score: 0.033
  41. Histologic and immunohistochemical decision-making in endometrial adenocarcinoma. Mod Pathol. 2008 Aug; 21(8):937-42.
    View in: PubMed
    Score: 0.024
  42. Biomarker-assisted diagnosis of ovarian, cervical and pulmonary small cell carcinomas: the role of TTF-1, WT-1 and HPV analysis. Histopathology. 2007 Sep; 51(3):305-12.
    View in: PubMed
    Score: 0.023
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.